Monitoring of Patients taking Canthaxanthin and Carotene: An Electroretinographic and Ophthalmological Survey
- 1 November 1989
- journal article
- research article
- Published by SAGE Publications in Human Toxicology
- Vol. 8 (6), 439-450
- https://doi.org/10.1177/096032718900800603
Abstract
1 Patients who have taken canthaxanthin and beta-carotene to avert phototoxicity have been monitored by electroretinographic testing. 2 Patients took the compounds only during the summer months, but were monitored for more than 1 year to determine if seasonal changes in the ERG were visible. 3 The characteristic refractile retinal crystals reduced during the winter. 4 The scotopic b-wave amplitude increased during the winter, whether evoked by red or blue flashes. 5 No other ERG parameter altered. 6 Changes noted in 3 and 4 above are reversible. 7 A dose/ERG-amplitude response relationship was established, but no correlation between blood level or total cumulative dose and b-wave amplitude could be found. 8 It is suggested that the Müller cells concentrate canthaxanthin and this is the mechanism which affects the ERG.This publication has 6 references indexed in Scilit:
- Static Perimetry in Canthaxanthin MaculopathyArchives of Ophthalmology (1950), 1988
- Canthaxanthin retinopathyAlbrecht von Graefes Archiv für Ophthalmologie, 1987
- Rod and cone activity in patients with dominantly inherited retinitis pigmentosa: comparisons between psychophysical and electroretinographic measurements.British Journal of Ophthalmology, 1983
- A modified ERG technique and the results obtained in X-linked retinitis pigmentosa.British Journal of Ophthalmology, 1983
- Photon-like signals following weak rhodopsin bleachesNature, 1981
- Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram.Journal of Neurophysiology, 1970